The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis.
Y Fujii,M Abe,T Higuchi,M Mizuno,H Suzuki,S Matsumoto,M Ito,N Maruyama,K Okada,M Soma
Expert Opin Pharmacother 2013 2;14(3):259- 67

Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report.
Y Noda,T Miyoshi,H Oe,Y Ohno,K Nakamura,N Toh,K Kohno,H Morita,K Kusano,H Ito
Cardiovasc Diabetol 2013 1;12(1):8

Percutaneous coronary intervention versus optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease.
S Bangalore,S Pursnani,S Kumar,PG Bagos
Circulation 2013 2;127(7):769-81

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
Murray CJ, Vos T, Lozano R
Lancet. 2013 Dec 15;380(9859):2197-223. doi: 10.1016/S0140-6736(12)61689-4.

Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk.
P Choudhary,J Shin,Y Wang,ML Evans,PJ Hammond,D Kerr,JA Shaw,JC Pickup,SA Amiel
Diabetes Care 2011 9;34(9):2023-5

A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.
N Mauras,R Beck,D Xing,K Ruedy,B Buckingham,M Tansey,NH White,SA Weinzimer,W Tamborlane,C Kollman
Diabetes Care 2012 2;35(2):204-10

Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes.
RA Vigersky,SJ Fonda,M Chellappa,MS Walker,NM Ehrhardt
Diabetes Care 2012 1;35(1):32-8

Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative.
AL Culver,IS Ockene,R Balasubramanian,BC Olendzki,DM Sepavich,J Wactawski-Wende,JE Manson,Y Qiao,S Liu,PA Merriam,C Rahilly-Tierny,F Thomas,JS Berger,JK Ockene,JD Curb,Y Ma
Arch Intern Med 2012 1;172(2):144-52

Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance.
E Ferrannini,A Natali,S Camastra,M Nannipieri,A Mari,KP Adam,MV Milburn,G Kastenmüller,J Adamski,T Tuomi,V Lyssenko,L Groop,WE Gall
Diabetes 2012 11;():